State authorities have begun an investigation into a cannabis testing lab over allegations of falsified testing results, according to the local newspaper the Tulsa World.
The FDA is looking to hire a contractor to study thousands of CBD product samples to help the administration develop regulations for products containing the compound.
Any lab analyst with a view on how mycotoxins and E.coli bacteria should be screened for in cannabis samples has been invited to comment on AOAC International’s own drafted methods.
Officials from Michigan’s Marijuana Regulatory Agency (MRA) have recalled nearly 3,200 pre-rolled cannabis cigarettes from 14 retail locations across the state following a “confirmed complaint regarding pre-rolls contaminated with human saliva.”
"There is no need for the world’s largest cannabis market to make these same mistakes," Antonio Frazier, a board member of the American Council of Independent Laboratories, tells Analytical Cannabis.
With over 70 known cannabinoids present in the cannabis plant, it's important that researchers and testing staff look at more than just the THC content when examining cannabis material. But how exactly do analysts profile and study these dozens of cannabinoids?
The Nevada Cannabis Compliance Board has begun investigating three state dispensaries for selling a product that twice failed microbial testing.
The scientists behind the new initiative at the National Institute of Standards and Technology also plan to help standardize the testing methods used for cannabis products, such as edibles, tinctures, and balms.
Discover how analytical testing procedures can often lead to contamination and sources of errors if not adequately addressed.